“Aprepitant, a novel neurokinin-1 receptor antagonist in management of chemotherapy induces nausea vomiting (CINV) in cancer patients”, Int. J. Res. Clin. Hosp. Pharm., vol. 2, no. 1, pp. 1–4, Sep. 2019, Accessed: May 25, 2026. [Online]. Available: https://rubatosisjournals.com/index.php/ijrhcp/article/view/333